Junzhao Yin

机构：Jiangsu Hengrui Medicine (China)

发表论文 5 篇 · 总被引 53 次 · h-index 4

代表论文

• Abstract LB031: SHR-A1811, a novel anti-HER2 ADC with superior bystander effect, optimal DAR and favorable safety profiles (2023 · Cancer Research · 被引 24)
• SHR-A1811, a novel anti-HER2 antibody–drug conjugate with optimal drug-to-antibody ratio, efficient tumor killing potency, and favorable safety profiles (2025 · PLoS ONE · 被引 17)
• Structure-based design and synthesis of bicyclic fused-pyridines as MEK inhibitors (2014 · Bioorganic & Medicinal Chemistry Letters · 被引 6)
• Discovery of SHR5428 as a selective and noncovalent inhibitor of CDK7 (2023 · Bioorganic & Medicinal Chemistry Letters · 被引 4)
• SHR-A1811, a novel anti-HER2 antibody–drug conjugate with optimal drug-to-antibody ratio, superior bystander killing effect and favorable safety profiles (2023 · Research Square · 被引 2)